Description

During the 32nd Meeting of the Indian Association for the Study of the Liver (INASL), Alexander Krag hosted a special EASL Studio session focusing on steatotic liver disease. The discussion explored the impact of the recent drug approval in the USA and reflected on the first year since the nomenclature change. What challenges and opportunities lie ahead for the field? Watch the expert discussion. 

Faculty

  • Aleksander Krag (Moderator)
  • Arun Sanyal (Faculty)
  • Rohit Loomba (Faculty)
  • Sven Francque (Faculty)
  • Francesco Paulo Russo (Faculty)
  • Shivaram Prasad Singh (Faculty)
  • Ajay Duseja (Faculty)

 

Log in to post comments